Keiser Wilhelms gate 24
Ålesund 6003
Norway
47 73 10 22 00
https://www.hofsethbiocare.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 69
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Jon Olav Odegard | Chief Executive Officer | 241.86k | N/A | N/A |
Ms. Christel Elise Kanli | CFO & COO | 123.19k | N/A | N/A |
Dr. Bomi Framroze | Chief Scientific Officer | 803.56k | N/A | 1961 |
Mr. James Berger | Chief Commercial Officer | 42.65k | N/A | N/A |
Ms. Angelika Florvaag | Chief Quality Officer | 107.27k | N/A | N/A |
Dr. Crawford Linden Alexander Currie | Head of Medical R&D and Director | 8.17k | N/A | N/A |
Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company's products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was incorporated in 2000 and is headquartered in Ålesund, Norway.
Hofseth BioCare ASA’s ISS Governance QualityScore as of May 1, 2024 is 10. The pillar scores are Audit: 10; Board: 9; Shareholder Rights: 10; Compensation: 10.